Systematic review and meta-analysis evaluate MRgFUS efficacy and safety in Parkinson’s disease, indicating a promising noninvasive alternative to DBS.
Magnetic resonance–guided focused ultrasound (MRgFUS) has emerged as a noninvasive alternative to deep brain stimulation (DBS) for Parkinson’s disease (PD). Although the subthalamic nucleus (STN) and globus pallidus internus (GPi) are well-established surgical targets, their relative effectiveness and safety when treated with MRgFUS have not been clearly defined.
No takes yet. Share an insight, caveat, or question.
Abbas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: